Hemotek
Hemotek specializes in developing powdered forms of oxygen as a research reagent.
Hemotek is a company in biopharma, biotechnology, manufacturing, pharmaceutical based in Dallas/Fort Worth Metroplex, Southern US, founded in 2008.
Hemotek is positioned in biopharma, biotechnology, manufacturing, pharmaceutical, a segment that rewards a clear, focused offering.
Its base of operations is Dallas/Fort Worth Metroplex, Southern US.
The company is listed at the SBIR/STTR stage of development.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $994K.
| Sector | Biopharma, Biotechnology, Manufacturing, Pharmaceutical |
|---|---|
| Headquarters | Dallas/Fort Worth Metroplex, Southern US |
| Country | UNITED STATES |
| Founded | 2008 |
| Employees | c_00011_00050 |
| Stage | SBIR/STTR |
| Total funding | $994,000 |
Website: www.hemotek.co.uk
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account